Qin Yi, Xuan Liping, Wu Zhe, Deng Yujie, Liu Bin, Wang Shujie
Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Endocrinology, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Sci Rep. 2024 Dec 2;14(1):29893. doi: 10.1038/s41598-024-81208-1.
Chronic kidney disease (CKD) is a complex condition with diverse etiology and outcomes. Utilizing a data-driven clustering approach holds promise in identifying distinct CKD subgroups associated with specific risk profiles for death.
Unsupervised consensus clustering was utilized to classify chronic kidney disease (CKD) into subtypes based on 45 baseline characteristics in a cohort of 6,526 participants from the US National Health and Nutrition Examination Survey (NHANES) spanning the years 1999-2000 to 2017-2018.We examined the associations between CKD subgroups and clinical endpoints related to mortality, including all-cause mortality, cardiovascular disease mortality, cancer mortality, and mortality due to other causes.
A total of 6,526 individuals with CKD were classified into four clusters at baseline. Cluster 1 (n = 508) comprised patients with relatively favorable levels of cardiac and kidney function markers, lower prevalence of cancer and higher prevalence of obesity, lower medication usage, and younger age. Cluster 4 (n = 2,029) comprised patients with the worst cardiac and kidney function markers. The characteristics of cluster 2 (n = 1,439) and 3 (n = 2,550) fell in between these two clusters. From cluster 1 to cluster 4, we observed a gradual increase in the hazard ratios of all-cause mortality, cardiovascular disease mortality, and mortality due to other causes. Additionally, further sensitivity analysis revealed patient heterogeneity among predefined subgroups with similar baseline kidney function and mortality risks.
Consensus clustering integrated baseline clinical and laboratory measures, revealing distinct CKD subgroups with markedly different risks of death, suggesting that further examination of patient subgroups could advance precision medicine.
慢性肾脏病(CKD)是一种病因多样、结局各异的复杂病症。采用数据驱动的聚类方法有望识别出与特定死亡风险特征相关的不同CKD亚组。
利用无监督一致性聚类,根据来自1999 - 2000年至2017 - 2018年美国国家健康与营养检查调查(NHANES)的6526名参与者队列中的45项基线特征,将慢性肾脏病(CKD)分为不同亚型。我们研究了CKD亚组与包括全因死亡率、心血管疾病死亡率、癌症死亡率及其他原因导致的死亡率等与死亡相关的临床终点之间的关联。
共有6526例CKD患者在基线时被分为四个聚类。聚类1(n = 508)包括心脏和肾脏功能标志物水平相对较好、癌症患病率较低、肥胖患病率较高、药物使用较少且年龄较轻的患者。聚类4(n = 2029)包括心脏和肾脏功能标志物最差的患者。聚类2(n = 1439)和聚类3(n = 2550)的特征介于这两个聚类之间。从聚类1到聚类4,我们观察到全因死亡率、心血管疾病死亡率及其他原因导致的死亡率的风险比逐渐增加。此外,进一步的敏感性分析揭示了在具有相似基线肾功能和死亡风险的预定义亚组中存在患者异质性。
一致性聚类整合了基线临床和实验室指标,揭示了具有明显不同死亡风险的不同CKD亚组,表明对患者亚组的进一步研究可能推动精准医学发展。